Graduate Program in Food and Nutrition, Federal University of Piauí, Teresina, PI, Brazil.
Nursing Departament, Federal University of Piauí, Teresina, PI, Brazil.
Nutrition. 2021 Nov-Dec;91-92:111457. doi: 10.1016/j.nut.2021.111457. Epub 2021 Aug 18.
In this review, we systematically assess whether dietary interventions are effective in attenuating inflammatory biomarkers in IBDs based on clinical trials available in the literature.
RESEARCH METHODS & PROCEDURES: This review was conducted in accordance with the guidelines of the PRISMA. We used the PubMed and SciVerse Scopus databases and the Cochrane collaboration tool to assess the risk of bias in clinical trials. The PICO (patient, intervention, comparison, and outcomes) strategy was used, with the descriptors: "Inflammatory bowel disease", "Crohn's disease", "cd", "ibd", "ulcerative colitis", "uc", "Diet", "Diet Habits", "Feeding", "Nutrients", "Food Intake", "Dietary patterns", "Inflammations", "Inflammation", "acute-phase proteins", "C-reactive protein", "interleukins", "tumor necrosis factor-alpha" and "inflammatory response". There is no conflict of interest.
Fifteen studies were included, with a total of 627 participants. Of the total studies included, seven showed a reduction in some inflammatory markers in response to dietary interventions. This review was registered with the PROSPERO platform under number: CRD42021235150.
The results presented in this review reveal that dietary intervention with specific characteristics may be important during the treatment of the inflammatory process in patients with IBDs.
在本综述中,我们系统地评估了基于文献中临床研究的饮食干预是否能有效减轻炎症性生物标志物在炎症性肠病中的作用。
本综述符合 PRISMA 指南。我们使用了 PubMed 和 SciVerse Scopus 数据库以及 Cochrane 协作工具来评估临床试验的偏倚风险。采用 PICO(患者、干预、比较和结局)策略,描述词为:“炎症性肠病”、“克罗恩病”、“cd”、“ibd”、“溃疡性结肠炎”、“uc”、“饮食”、“饮食习惯”、“喂养”、“营养素”、“食物摄入”、“饮食模式”、“炎症”、“炎症”、“急性期蛋白”、“C 反应蛋白”、“白细胞介素”、“肿瘤坏死因子-α”和“炎症反应”。无利益冲突。
纳入了 15 项研究,共计 627 名参与者。在纳入的所有研究中,有 7 项研究显示饮食干预后某些炎症标志物有所降低。本综述已在 PROSPERO 平台上注册,编号为:CRD42021235150。
本综述的结果表明,在炎症性肠病患者的炎症过程治疗中,具有特定特征的饮食干预可能很重要。